Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013
- PMID: 30782488
- PMCID: PMC6466626
- DOI: 10.1016/j.vaccine.2019.02.008
Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013
Abstract
Background: Afghanistan remains among the three countries with endemic wild poliovirus transmission, and high population immunity levels are required to interrupt transmission and prevent outbreaks. Surveillance and vaccination of children in Afghanistan have been challenging due to security issues limiting accessibility in certain areas.
Methods: A serosurvey was conducted in 2013 within accessible enumeration areas (EAs) among children aged <5 years using samples collected for a national micronutrient assessment survey to assess poliovirus immunity in Afghanistan. Of 21194 total EAs in Afghanistan, 107 were inaccessible and therefore were excluded from the sampling frame.
Results: Population immunity was high overall but varied for the poliovirus serotypes, and was lowest for type 3 (95% [95% CI: 93%, 96%]) compared to type 1 (99% [95% CI:97%, 99%]) and type 2 (98% [95% CI:96%, 99%]). The proportion of the population immune to all three types was 93% (95% CI: 91%, 95%), and the proportion seronegative for all three types was 0.5% (95% CI: 0.2%, 1.7%).
Conclusion: Except for regional differences in immunity to type 3 virus, there were no other apparent differences in seroprevalence by region or by any of the demographic or nutritional characteristics assessed in this study. The study was not powered to provide provincial level seroprevalence estimates, but Paktika Province, in the South region, had the largest proportion of seronegative specimens for type 1 (4 seronegative of 17 serum specimens compared to 14 seronegative of 673 for the remainder of the areas). Among accessible children in Afghanistan, seroprevalence of antibodies to poliovirus was high, with most seroprevalence reported at 95% or greater. Despite high seroprevalence in areas assessed in this study, the continued detection of poliovirus cases in the South and East regions indicate that overall regional vaccination coverage and performance is not sufficient to stop polio transmission.
Keywords: Afghanistan; Eradication; Immunity; Poliovirus; Serosurvey.
Published by Elsevier Ltd.
Conflict of interest statement
Conflicts of interest
All co-authors report no potential conflicts of interest.
Figures
Similar articles
-
The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.Lancet. 2012 Aug 4;380(9840):491-8. doi: 10.1016/S0140-6736(12)60648-5. Epub 2012 Jul 4. Lancet. 2012. PMID: 22766207 Free PMC article.
-
Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014.J Infect Dis. 2016 May 1;213 Suppl 3(Suppl 3):S124-30. doi: 10.1093/infdis/jiv774. Epub 2016 Feb 9. J Infect Dis. 2016. PMID: 26908720 Free PMC article.
-
Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan.J Infect Dis. 2025 Feb 20;231(2):e438-e445. doi: 10.1093/infdis/jiae129. J Infect Dis. 2025. PMID: 38597896 Free PMC article.
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2. Cochrane Database Syst Rev. 2019. PMID: 31801180 Free PMC article.
-
Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.Lancet Infect Dis. 2019 Oct;19(10):1121-1128. doi: 10.1016/S1473-3099(19)30301-9. Epub 2019 Jul 23. Lancet Infect Dis. 2019. PMID: 31350192
Cited by
-
Poliovirus Immunity among Children Aged 6-11 and 36-48 Months in 14 Polio High-Risk Provinces of Afghanistan: A Health-Facility-Based Study.Vaccines (Basel). 2022 Oct 16;10(10):1726. doi: 10.3390/vaccines10101726. Vaccines (Basel). 2022. PMID: 36298591 Free PMC article.
References
-
- Farag NH, Wadood Mz, Safdar RM, et al. Progress toward poliomyelitis eradication-Pakistan, January 2014-September 2015. MMWR Morb Mortal Wkly Rep 2015;64(45):1271–5. - PubMed
-
- Hsu CH, Mahamud A, Safdar RM, et al. Progress toward poliomyelitis eradication - Pakistan, January 2015-September 2016. MMWR Morb Mortal Wkly Rep 2016;65(46):1295–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical